Correlation Between Agios Pharm and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Alzamend Neuro, you can compare the effects of market volatilities on Agios Pharm and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Alzamend Neuro.
Diversification Opportunities for Agios Pharm and Alzamend Neuro
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Agios and Alzamend is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Agios Pharm i.e., Agios Pharm and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Agios Pharm and Alzamend Neuro
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.92 times more return on investment than Alzamend Neuro. However, Agios Pharm is 1.08 times less risky than Alzamend Neuro. It trades about 0.4 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.21 per unit of risk. If you would invest 4,443 in Agios Pharm on September 1, 2024 and sell it today you would earn a total of 1,496 from holding Agios Pharm or generate 33.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Alzamend Neuro
Performance |
| Timeline |
| Agios Pharm |
| Alzamend Neuro |
Agios Pharm and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Alzamend Neuro
The main advantage of trading using opposite Agios Pharm and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Alzamend Neuro vs. Tff Pharmaceuticals | Alzamend Neuro vs. Eliem Therapeutics | Alzamend Neuro vs. Inhibrx | Alzamend Neuro vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |